Skeletal muscle dysfunction in critical care: Wasting, weakness, and rehabilitation strategies

Critical Care Medicine

Volumn 38, Issue 10 SUPPL., 2010, Pages

  Puthucheary, Zudin ^a   Harridge, Stephen ^a   Hart, Nicholas ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b National Institute of Health Research Comprehensive Biomedical Research Centre   (United Kingdom)

Author keywords

Critical illness; Muscle protein turnover; Muscle weakness; Muscle signaling pathways

Indexed keywords

ATROGIN 1; MUSCLE PROTEIN; MUSCLE RING FINGER 1 PROTEIN;

CONFERENCE PAPER; CRITICALLY ILL PATIENT; DISABILITY; ECHOGRAPHY; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MULTIPLE ORGAN FAILURE; MUSCLE ATROPHY; MUSCLE HYPERTROPHY; MUSCLE NECROSIS; MUSCLE WEAKNESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 78650321319     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181f2458d     Document Type: Conference Paper

References (99)

1. Herridge MS, Cheung AM, Tansey CM, et al: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003;348:683-693
2. Chelluri L, Im KA, Belle SH, et al: Long-term mortality and quality of life after prolonged mechanical ventilation. Crit Care Med 2004;32:61-69
3. Niskanen M, Kari A, Halonen P: Five-year survival after intensive care-comparison of 12, 180 patients with the general population. Finnish ICU Study Group. Crit Care Med 1996;24:1962-1967
4. National Institute for Health and Clinical Excellence: Rehabilitation after critical illness. NICE clinical guideline 83. Available at: http://www.nice.org.uk/nicemedia/live/12137/43526/43526.pdf. Published March 2009. Accessed August 23, 2010
5. De Jonghe B, Sharshar T, Lefaucheur JP, et al: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002;288:2859-2867
6. Latronico N, Shehu I, Seghelini E: Neuro-muscular sequelae of critical illness. Curr Opin Crit Care 2005;11:381-390
7. Latronico N, Peli E, Botteri M: Critical illness myopathy and neuropathy. Curr Opin Crit Care 2005;11:126-132
8. De Jonghe B, Sharshar T, Hopkinson N, et al: Paresis following mechanical ventilation. Curr Opin Crit Care 2004;10:47-52
9. Griffiths RD, Jones C: Recovery from intensive care. BMJ 1999;319:427-429
10. Coakley JH, Nagendran K, Yarwood GD, et al: Patterns of neurophysiological abnormality in prolonged critical illness. Intensive Care Med 1998;24:801-807
11. Fletcher SN, Kennedy DD, Ghosh IR, et al: Persistent neuromuscular and neurophysio-logic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003;31:1012-1016
12. Guarneri B, Bertolini G, Latronico N: Long-term outcome in patients with critical illness myopathy or neuropathy: The Italian multi-centre CRIMYNE study. J Neurol Neurosurg Psychiatry 2008;79:838-841
13. de Sèze M, Petit H, Wiart L, et al: Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol 2000;43:61-69
14. De Jonghe B, Bastuji-Garin S, Durand MC, et al: Respiratory weakness is associated with limb weakness and delayed weaning in critical illness. Crit Care Med 2007;39:2007-2015
15. Sharshar T, Bastuji-Garin S, Stevens RD, et al: Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med 2009;37:3047-3053
16. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, et al: Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-1296
17. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL, et al: Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005;33:349-354
18. Ali NA, O'Brien JM Jr, Hoffmann SP, et al: Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Re-spir Crit Care Med 2008;178:261-268
19. Tabary JC, Tabary C, Tardieu C, et al: Physiological and structural changes in the cat's soleus muscle due to immobilization at different lengths by plaster casts. J Physiol 1972;224:231-244
20. Tomanek RJ, Lund DD: Degeneration of different types of skeletal muscle fibres. II. Immobilization. J Anat 1974;118:531-541
21. Fischbach GD, Robbins N: Changes in contractile properties of disused soleus muscles. J Physiol 1969;201:305-320
22. Duchateau J, Hainaut K: Electrical and mechanical changes in immobilized human muscle. J Appl Physiol 1987;62:2168-2173
23. Kortebein P, Ferrando A, Lombeida J, et al: Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007;297:1772-1774
24. Kortebein P, Symons TB, Ferrando A, et al: Functional impact of 10 days of bed rest in healthy older adults. J Gerontol A Biol Sci Med Sci 2008;63:1076-1081
25. Gibson JN, Halliday D, Morrison WL, et al: Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. Clin Sci (Lond) 1987;72:503-509
26. Seki K, Taniguchi Y, Narusawa M: Alterations in contractile properties of human skeletal muscle induced by joint immobilization. J Physiol 2001;530:521-532
27. Schweickert WD, Pohlman MC, Pohlman AS, et al: Early physical and occupational therapy in mechanically ventilated, critically ill patients: A randomised controlled trial. Lancet 2009;373:1874-1882
28. Polkey MI, Kyroussis D, Hamnegard CH, et al: Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996;19:549-555
29. Swallow EB, Gosker HR, Ward KA, et al: A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 2007;103:739-746
30. Harris ML, Luo YM, Watson AC, et al: Adductor pollicis twitch tension assessed by magnetic stimulation of the ulnar nerve. Am J Respir Crit Care Med 2000;162:240-245
31. Harris ML, Moxham J: Measuring respiratory and limb muscle strength using magnetic stimulation: Measuring respiratory and limb muscle strength using magnetic stimulation. Br J Int Care 1998;8:21-28
32. Mills GH, Ponte J, Hamnegard CH, et al: Tracheal tube pressure change during magnetic stimulation of the phrenic nerves as an indicator of diaphragm strength on the intensive care unit. Br J Anaesth 2001;87:876-884
33. Pickles JKS, Harris ML, et al: Medium to long-term outcomes of critical illness hand muscle weakness. Abstract. Am J Respir Crit Care Med 2004;169:783
34. Seymour JM, Ward K, Sidhu PS, et al: Ultrasound measurement of rectus femoris cross-sectional area and the relationship to quadriceps strength in COPD. Thorax 2009;64:418-423
35. Narici MV, Landoni L, Minetti AE: Assessment of human knee extensor muscles stress from in vivo physiological cross-sectional area and strength measurements. Eur J Appl Physiol Occup Physiol 1992;65:438-444
36. Campbell IT, Watt T, Withers D, et al: Muscle thickness, measured with ultrasound, may be an indicator of lean tissue wasting in multiple organ failure in the presence of edema. Am J Clin Nutr 1995;62:533-539
37. Chi-Fishman G, Hicks JE, Cintas HM, et al: Ultrasound imaging distinguishes between normal and weak muscle. Arch Phys Med Rehabil 2004;85:980-986
38. Freilich RJ, Kirsner RL, Byrne E: Isometric strength and thickness relationships in human quadriceps muscle. Neuromuscul Disord 1995;5:415-422
39. Abe T, Kawakami Y, Suzuki Y, et al: Effects of 20 days bed rest on muscle morphology. J Gravit Physiol 1997;4: S10-S14
40. Bleakney R, Maffulli N: Ultrasound changes to intramuscular architecture of the quadriceps following intramedullary nailing. J Sports Med Phys Fitness 2002;42:120-125
41. Ellis S, Kirby LC, Greenleaf JE: Lower extremity muscle thickness during 30-day 6 degrees head-down bed rest with isotonic and isokinetic exercise training. Aviat Space Environ Med 1993;64:1011-1015
42. Akima H, Kawakami Y, Kubo K, et al: Effect of short-duration spaceflight on thigh and leg muscle volume. Med Sci Sports Exerc 2000;32:1743-1747
43. Uremovic M, Pasic MB, Seric V, et al: Ultrasound measurement of the volume of mus-culus quadriceps after knee joint injury. Coll Antropol 2004;28(Suppl 2):227-233
44. Reid CL, Campbell IT, Little RA: Muscle wasting and energy balance in critical illness. Clin Nutr 2004;23:273-280
45. Gruther W, Benesch T, Zorn C et al: Muscle wasting in intensive care patients: Ultrasound observation of the M. quadriceps fem-oris muscle layer. J Rehabil Med 2008;40:185-189
46. Khan J, Harrison TB, Rich MM: Mechanisms of neuromuscular dysfunction in critical illness. Crit Care Clin 2008;24:165-177, x
47. Truong AD, Fan E, Brower RG, et al: Bench-to-bedside review: Mobilizing patients in the intensive care unit-from pathophysiology to clinical trials. Crit Care 2009;13:216
48. Phillips SM, Glover EI, Rennie MJ: Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. J Appl Physiol 2009;107:645-654
49. Greenhaff PL, Karagounis LG, Peirce N, et al: Disassociation between the effects of amino acids and insulin on signaling, ubiquitin li-gases, and protein turnover in human muscle. Am J Physiol 2008;295: E595-E604
50. Murton AJ, Constantin D, Greenhaff PL: The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008;1782:730-743
51. de Boer MD, Selby A, Atherton P, et al: The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 2007;585:241-251
52. Paddon-Jones D, Sheffield-Moore M, Cree MG, et al: Atrophy and impaired muscle protein synthesis during prolonged inactivity and stress. J Clin Endocrinol Metab 2006;91:4836-4841
53. Rennie MJ: Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 1985;41:257-264
54. Glover EI, Phillips SM, Oates BR, et al: Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion. J Physiol 2008;586:6049-6061
55. Volpi E, Mittendorfer B, Rasmussen BB, et al: The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab 2000;85:4481-4490
56. Cuthbertson D, Smith K, Babraj J, et al: Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 2005;19:422-424
57. Hermans G, Wilmer A, Meersseman W, et al: Impact of intensive insulin therapy on neu-romuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007;175:480-489
58. Dulloo AG, Girardier L: Adaptive changes in energy expenditure during refeeding following low-calorie intake: Evidence for a specific metabolic component favoring fat storage. Am J Clin Nutr 1990;52:415-420
59. Reid CL, Murgatroyd PR, Wright A, et al: Quantification of lean and fat tissue repletion following critical illness: A case report. Crit Care 2008;12: R79
60. Wolfe RR: Regulation of skeletal muscle protein metabolism in catabolic states. Curr Opin Clin Nutr Metab Care 2005;8:61-65
61. Kandarian SC, Jackman RW: Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006;33:155-165
62. Jackman RW, Kandarian SC: The molecular basis of skeletal muscle atrophy. Am J Physiol 2004;287: C834-C843
63. Tiao G, Hobler S, Wang JJ, et al: Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 1997;99:163-168
64. Léger B, Senese R, Al-Khodairy AW, et al: Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 2009;40:69-78
65. Bodine SC, Latres E, Baumhueter S, et al: Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001;294:1704-1708
66. Lecker SH, Solomon V, Mitch WE, et al: Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J Nutr 1999;129(Suppl 1 S): 227S-237S
67. Lecker SH, Jagoe RT, Gilbert A, et al: Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004;18:39-51
68. Sandri M, Lin J, Handschin C, et al: PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 2006;103:16260-16265
69. Sacheck JM, Hyatt JP, Raffaello A, et al: Rapid disuse and denervation atrophy involve tran-scriptional changes similar to those of muscle wasting during systemic diseases. FASEB J 2007;21:140-155
70. Kimball SR, O'Malley JP, Anthony JC, et al: Assessment of biomarkers of protein anabo-lism in skeletal muscle during the life span of the rat: Sarcopenia despite elevated protein synthesis. Am J Physiol 2004;287: E772-E780
71. Tawa NE Jr, Odessey R, Goldberg AL: Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest 1997;100:197-203
72. Adams GR, McCue SA: Localized infusion of IGF-I results in skeletal muscle hypertrophy in rats. J Appl Physiol 1998;84:1716-1722
73. Hameed M, Orrell RW, Cobbold M, et al: Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 2003;547:247-254
74. Yarasheski KE, Zachwieja JJ, Campbell JA, et al: Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol 1995;268: E268-E276
75. DeVol DL, Rotwein P, Sadow JL, et al: Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 1990;259: E89-E95
76. Rommel C, Bodine SC, Clarke BA, et al: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3) K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat Cell Biol 2001;3:1009-1013
77. Bodine SC, Stitt TN, Gonzalez M, et al: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001;3:1014-1019
78. Murgia M, Serrano AL, Calabria E, et al: Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat Cell Biol 2000;2:142-147
79. Chen WS, Xu PZ, Gottlob K, et al: Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001;15:2203-2208
80. Deldicque L, Atherton P, Patel R, et al: Decrease in Akt/PKB signalling in human skeletal muscle by resistance exercise. Eur J Appl Physiol 2008;104:57-65
81. Reynolds TH 4th, Bodine SC, Lawrence JC Jr: Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem 2002;277:17657-17662
82. Bhasin S, Storer TW, Berman N, et al: The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335:1-7
83. Takala J, Ruokonen E, Webster NR: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-792
84. Otto A, Patel K: Signalling and the control of skeletal muscle size. Exp Cell Res 2010 Apr. 18. [Epub ahead of print]
85. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 2010;13:225-229
86. Stevens RD, Hart N, de Jonghe B, et al: Weakness in the ICU: A call to action. Crit Care 2009;13:1002
87. Puthucheary Z, Hart N: Intensive care unit acquired muscle weakness: When should we consider rehabilitation? Crit Care 2009;13:167
88. Zanni JM, Korupolu R, Fan E, et al: Rehabilitation therapy and outcomes in acute respiratory failure: An observational pilot project. J Crit Care 2009;25:254-262
89. Burtin C, Clerckx B, Robbeets C, et al: Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 2009;37:2499-2505
90. Cuthbertson BH, Rattray J, Campbell MK, et al: The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: A pragmatic randomised controlled trial. BMJ 2009;339: b3723
91. Mador MJ, Kufel TJ, Pineda LA, et al: Effect of pulmonary rehabilitation on quadriceps fa-tiguability during exercise. Am J Respir Crit Care Med 2001;163:930-935
92. Kumar V, Selby A, Rankin D, et al: Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J Physiol 2009;587:211-217
93. Morris PE, Goad A, Thompson C, et al: Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008;36:2238-2243
94. Needham DM: Mobilizing patients in the intensive care unit: Improving neuromuscular weakness and physical function. JAMA 2008;300:1685-1690
95. Gibson JN, Smith K, Rennie MJ: Prevention of disuse muscle atrophy by means of electrical stimulation: Maintenance of protein synthesis. Lancet 1988;2:767-770
96. Gerovasili V, Stefanidis K, Vitzilaios K, et al: Electrical muscle stimulation preserves the muscle mass of critically ill patients: A randomized study. Crit Care 2009;13: R161
97. Neder JA, Sword D, Ward SA, et al: Home based neuromuscular electrical stimulation as a new rehabilitative strategy for severely disabled patients with chronic obstructive pulmonary disease (COPD). Thorax 2002;57:333-337
98. Zanotti E, Felicetti G, Maini M, et al: Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest 2003;124:292-296
99. Vivodtzev I, Pépin JL, Vottero G, et al: Improvement in quadriceps strength and dyspnea in daily tasks after 1 month of electrical stimulation in severely deconditioned and malnourished COPD. Chest 2006;129:1540-1548